WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: TERLIVAZ TERLIPRESSIN FOR INJECTION

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on TERLIVAZ TERLIPRESSIN FOR INJECTION

Mark Identification

Proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION

We do not have any records of a proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION at this moment.

Click here to add a proof of use for TERLIVAZ TERLIPRESSIN FOR INJECTION

Possible trademark infringements of TERLIVAZ TERLIPRESSIN FOR INJECTION

Basic Information about TERLIVAZ TERLIPRESSIN FOR INJECTION

Serial Number
88900093
Filing Date
04 May 2020
Registration Number
7081079
Registration Date
13 Jun 2023
Mark Drawing Code
3

Classifications

Declare the trademark use of TERLIVAZ TERLIPRESSIN FOR INJECTION on the blockchain with WikiTrademarks.io.

First use of TERLIVAZ TERLIPRESSIN FOR INJECTION anywhere
TERLIVAZ TERLIPRESSIN FOR INJECTION was first used on 12 Oct 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
005; 006; 018; 044; 046; 051; 052

Correspondent

Carlynn Ferguson
IPHORGAN LTD.
195 NORTH ARLINGTON HEIGHTS ROAD
SUITE 125

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on TERLIVAZ TERLIPRESSIN FOR INJECTION